Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation

Douglas M. Dahl, Theodore G. Karrison, M. Dror Michaelson, Huong T. Pham, Chin Lee Wu, Gregory P. Swanson, William U. Shipley, Jacqueline Vuky, R. Jeffrey Lee, Anthony L. Zietman, Luis Souhami, Brian K. Chang, Richard L. Deming, John A. Ellerton, Howard M. Sandler, Joseph P. Rodgers, Felix Y. Feng, Jason A. Efstathiou

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation'. Together they form a unique fingerprint.

Medicine & Life Sciences